AskMed

TIMI score for NSTEMI vs STEMI: two different scores

"TIMI score" can mean two scores published two months apart in 2000 by the same research group. One is for unstable angina and non-ST elevation MI and predicts events over 14 days; the other is for ST-elevation MI and predicts death at 30 days. Here is what each counts, how each is read, and which one fits which patient.

Open the TIMI score calculator

What the TIMI risk score for UA/NSTEMI measures

The TIMI risk score for unstable angina and non-ST elevation myocardial infarction was published by Antman and colleagues in JAMA in August 2000. It was derived in 1957 patients with UA/NSTEMI from the TIMI 11B trial and validated in 3 more trial cohorts from TIMI 11B and ESSENCE. It counts 7 predictors at 1 point each: age 65 or older, at least 3 risk factors for coronary artery disease, prior coronary stenosis of 50% or more, ST-segment deviation on the presenting ECG, at least 2 anginal events in the prior 24 hours, use of aspirin in the prior 7 days, and elevated serum cardiac markers. The total runs from 0 to 7. The outcome is a composite of all-cause death, new or recurrent myocardial infarction, or severe recurrent ischemia requiring urgent revascularization through 14 days, and its rate rose from 4.7% at a score of 0 or 1 to 40.9% at 6 or 7.

This is the score the TIMI score calculator on this site works out, with the 14-day rate for each score from the original paper.

What the TIMI risk score for STEMI measures

The TIMI risk score for ST-elevation myocardial infarction is a separate score, published by Morrow and colleagues in Circulation in October 2000. It was built from 14,114 fibrinolytic-eligible patients with STEMI in the InTIME II trial (Intravenous nPA for Treatment of Infarcting Myocardium Early II), and it predicts death within 30 days. Unlike the UA/NSTEMI score, its points are weighted: each predictor carries points according to its adjusted odds ratio from logistic regression, for a total from 0 to 14. The paper reports that its ten baseline variables accounted for 97% of the predictive capacity of the full multivariable model. Mean 30-day mortality in the trial was 6.7%. Mortality rose more than 40-fold across the score, from under 1% at 0 points to 35.9% above 8. The c statistic was 0.779, against 0.784 for the full model, performance held from 1 to 365 days, and external validation in the TIMI 9 trial gave 0.746.

TIMI STEMI predictorPoints
Age 65–74 years2
Age 75 years or older3
Diabetes, hypertension or angina1
Systolic blood pressure below 100 mmHg3
Heart rate above 100 per minute2
Killip class II–IV2
Weight below 67 kg1
Anterior ST elevation or left bundle branch block1
Time to treatment over 4 hours1
Total0–14

30-day mortality by TIMI STEMI score in InTIME II (Morrow 2000):

Score012345678Over 8
30-day death0.8%1.6%2.2%4.4%7.3%12.4%16.1%23.4%26.8%35.9%

AskMed does not build the STEMI score as a calculator; this page describes it from Morrow's paper so the two are not confused.

How the two TIMI scores differ

The two TIMI scores differ in almost everything except their name and their authors, the TIMI investigators at Brigham and Women's Hospital in Boston. The UA/NSTEMI score uses 7 equal yes-or-no items and a range of 0 to 7; the STEMI score uses weighted items and a range of 0 to 14. The UA/NSTEMI score predicts a composite of death, myocardial infarction or urgent revascularization over 14 days; the STEMI score predicts death alone over 30 days. Only age appears in both, and with different cut-offs: one point at 65 or older in the UA/NSTEMI score, against 2 points at 65 to 74 and 3 points at 75 or older in the STEMI score. The UA/NSTEMI score includes the coronary history, aspirin use and cardiac markers; the STEMI score instead uses hemodynamic findings, weight, infarct location and time to treatment. The STEMI score also separated outcomes better, with a c statistic of 0.779 against 0.65 for the UA/NSTEMI composite.

FeatureTIMI for UA/NSTEMITIMI for STEMI
PaperAntman, JAMA, August 2000Morrow, Circulation, October 2000
Derivation cohort1957 patients, TIMI 11B14,114 patients, InTIME II
PatientsUnstable angina or non-ST elevation MIFibrinolytic-eligible ST-elevation MI
Items and weighting7 items, 1 point eachWeighted by adjusted odds ratio
Range0–70–14
OutcomeDeath, new or recurrent MI, or urgent revascularization, 14 daysAll-cause death, 30 days
Rate at the bottom and top4.7% at 0–1, 40.9% at 6–70.8% at 0, 35.9% above 8
c statistic (derivation)0.650.779

Which TIMI score fits which patient

Which TIMI score to use depends first on the electrocardiogram. A patient with ST-elevation MI belongs to the Morrow score, which was built in patients eligible for fibrinolysis and estimates death at 30 days. A patient with an acute coronary syndrome and no ST elevation, meaning unstable angina or NSTEMI, belongs to the Antman score, which estimates death, infarction or urgent revascularization at 14 days. ST depression on the presenting ECG counts as a point in the UA/NSTEMI score; it does not make a STEMI. Neither TIMI score was designed for every patient who walks in with chest pain: both were derived in trial populations with a confirmed diagnosis. For undifferentiated chest pain in the emergency department, Backus and colleagues found that the HEART score separated 6-week outcomes better than the UA/NSTEMI TIMI score, with c statistics of 0.83 against 0.75 in 2388 patients at 10 Dutch hospitals.

Use the HEART score calculator for that first look at chest pain, and the TIMI score calculator once UA/NSTEMI is the working diagnosis. The guide HEART vs TIMI vs GRACE covers how those three compared head to head.

Worked examples: one patient for each score

Two patients show how differently the two TIMI scores are built and read. The first is a 68-year-old man with hypertension, diabetes and current smoking, who took aspirin this week, has never had a cardiac catheterization, and had one episode of chest pain at rest today. His ECG shows ST depression and his troponin is raised, so the diagnosis is NSTEMI. On the UA/NSTEMI score he gets 1 point each for age, 3 risk factors, ST deviation, aspirin use and raised markers: 5 points. In the TIMI 11B test cohort, 26.2% of patients with a score of 5 had an event by day 14, and 7.1% died. The second is a 70-year-old woman with hypertension and an anterior STEMI, 2 hours after symptom onset, weighing 62 kg, with a heart rate of 104, a systolic pressure of 110 mmHg and clear lungs (Killip class I). Her STEMI score is 7 points.

PatientScore usedPointsTotalRisk in the source paper
68-year-old man, NSTEMITIMI for UA/NSTEMIAge 1, risk factors 1, ST deviation 1, aspirin 1, markers 15 of 726.2% death, MI or urgent revascularization at 14 days
70-year-old woman, anterior STEMITIMI for STEMIAge 2, hypertension 1, heart rate 2, weight 1, anterior ST elevation 17 of 1423.4% death at 30 days

The two totals cannot be compared with each other: a 5 on one scale and a 7 on the other measure different outcomes over different time spans. Enter the first patient in the TIMI score calculator to see the same 26.2%.

Questions

Is the TIMI score used for STEMI?

There is a TIMI score for STEMI, but it is not the 7-item score. Morrow's TIMI risk score for STEMI weights its items, runs from 0 to 14 and predicts death at 30 days.

Does ST depression make a patient a STEMI for TIMI scoring?

No. ST depression on the presenting ECG is the ST deviation item of the UA/NSTEMI score and adds 1 point there. The STEMI score is for ST-elevation MI.

What is the highest TIMI score?

7 for the UA/NSTEMI score, where 6 or 7 points carried a 40.9% 14-day event rate, and 14 for the STEMI score, where scores above 8 carried 35.9% mortality at 30 days.

Which patients was the TIMI STEMI score built in?

Fibrinolytic-eligible patients with STEMI in the InTIME II trial, with external validation in the TIMI 9 trial. Morrow's paper describes it as a score for the triage and management of fibrinolytic-eligible patients.

Can AskMed explain cardiac risk scores with sources?

Yes. AskMed answers from guidelines and journals, with a citation after every claim, and does not give doses. It is on the App Store and Google Play, or use it on the web.

Sources

  1. Antman EM, Cohen M, Bernink PJLM, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835–842. doi:10.1001/jama.284.7.835
  2. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102(17):2031–2037. doi:10.1161/01.CIR.102.17.2031
  3. Backus BE, Six AJ, Kelder JC, et al. A prospective validation of the HEART score for chest pain patients at the emergency department. Int J Cardiol. 2013;168(3):2153–2158. doi:10.1016/j.ijcard.2013.01.255

Cited medical answers
you can trust.

AskMed on iPhone, iPad, Android and the web.